NCT03014700View on ClinicalTrials.gov

Fibrinogen Concentrate vs Cryoprecipitate

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

April 25, 2018

Study Completion Date

April 25, 2018

Conditions
Congenital Heart Disease
Interventions
BIOLOGICAL

Fibrinogen Concentrate

Subject will be administered Fibrinogen Concentrate to control bleeding after open heart surgery when randomized to Fibrinogen Concentrate group

BIOLOGICAL

Cryoprecipitate

Subject will be administered Cryoprecipitate to control bleeding after open heart surgery when randomized to Cryoprecipitate group

Trial Locations (2)

30322

Laura Downey, Emory

94305

Stanford University Medical Center, Stanford

All Listed Sponsors
collaborator

Emory University

OTHER

lead

Stanford University

OTHER

NCT03014700 - Fibrinogen Concentrate vs Cryoprecipitate | Biotech Hunter | Biotech Hunter